Related Experiment Video
Updated: Aug 9, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Suppression of keratinocyte growth and differentiation by transforming growth factor beta1 involves multiple
A L Dahler1, L L Cavanagh, N A Saunders
1Epithelial Pathobiology Group, Center for Immunology and Cancer Research, University of Queensland Department of Medicine, Princess Alexandra Hospital, Ipswich Road, Brisbane, Queensland, Australia 4102.
Abstract:
Transforming growth factor beta1 treatment of keratinocytes results in a suppression of differentiation, an induction of extracellular matrix production, and a suppression of growth. In this study we utilized markers specific for each of these functions to explore the signaling pathways involved in mediating these transforming-growth-factor-beta1-induced activities. In the first instance, we found that the induction of extracellular matrix production (characterized by 3TP-Lux reporter activity) was induced in both keratinocytes and a keratinocyte-derived carcinoma cell line, SCC25, in a dose-dependent manner. Furthermore, transforming growth factor beta1 also suppressed the differentiation-specific marker gene, transglutaminase type 1, in both keratinocytes and SCC25 cells. In contrast, transforming growth factor beta1 inhibited proliferation of keratinocytes but did not cause growth inhibition in the SCC25 cells. Transforming-growth-factor-beta1-induced growth inhibition of keratinocytes was characterized by decreases in DNA synthesis, accumulation of hypophosphorylated Rb, and the inhibition of the E2F:Rb-responsive promoter, cdc2, and an induction of the p21 promoter. When the negative regulator of transforming growth factor beta1 signaling, SMAD7, was overexpressed in keratinocytes it could prevent transforming-growth-factor-beta1-induced activation of the 3TP-Lux and the p21 promoter. SMAD7 could also prevent the suppression of the transglutaminase type 1 by transforming growth factor beta1 but it could not inhibit the repression of the cdc2 promoter. These data indicate that the induction of 3TP-Lux and p21 and the suppression of transglutaminase type 1 are mediated by a different proximate signaling pathway to that regulating the suppression of the cdc2 gene. Combined, these data indicate that the regulation of transforming growth factor beta1 actions are complex and involve multiple signaling pathways.
Insights
Transforming growth factor beta1 (TGF-β1) impacts keratinocytes by altering differentiation, extracellular matrix production, and growth. TGF-β1 signaling involves complex pathways, with SMAD7 regulating some but not all TGF-β1-induced effects.
Area of Science:
- Cell Biology
- Molecular Biology
- Dermatology
Background:
- Transforming growth factor beta1 (TGF-β1) is a key regulator of keratinocyte function.
- TGF-β1 influences crucial cellular processes including differentiation, extracellular matrix production, and proliferation.
Purpose of the Study:
- To investigate the specific signaling pathways mediating TGF-β1's diverse effects on keratinocytes.
- To differentiate the pathways responsible for TGF-β1-induced extracellular matrix production, growth suppression, and differentiation changes.
Main Methods:
- Utilized keratinocytes and SCC25 cell lines.
- Employed reporter gene assays (3TP-Lux) to measure extracellular matrix production.
- Assessed differentiation marker gene (transglutaminase type 1) expression.
- Monitored proliferation, DNA synthesis, and cell cycle regulatory proteins (Rb, p21, cdc2).
- Investigated the role of SMAD7, a negative regulator of TGF-β1 signaling.
Main Results:
- TGF-β1 dose-dependently induced extracellular matrix production and suppressed transglutaminase type 1 in both cell types.
- TGF-β1 inhibited keratinocyte proliferation via decreased DNA synthesis and altered cell cycle regulators (Rb, p21, cdc2).
- SCC25 cells showed no TGF-β1-induced growth inhibition.
- Overexpression of SMAD7 blocked TGF-β1-induced 3TP-Lux and p21 activation, and transglutaminase type 1 suppression, but not cdc2 repression.
Conclusions:
- TGF-β1 actions on keratinocytes are complex and mediated by multiple distinct signaling pathways.
- The pathways regulating extracellular matrix production and differentiation suppression differ from those controlling cell cycle inhibition.
- SMAD7 differentially affects TGF-β1-induced signaling events, highlighting pathway specificity.
More Related Videos
Related Concept Videos
Hedgehog Signaling Pathway
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
TGF - β Signaling Pathway

